As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).

Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...

The technology is part of a broader industry shift towards precision medicine, says GlobalData analyst Cynthia Stinchcombe.

Cassava alleged that the short sellers had launched a “short and distort” campaign which caused a “decline in Cassava ...

DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.

Viking Therapeutics has announced positive results from its Phase Ib trial of VK0214 in patients with X-linked ...

Chicago-based Vanqua Bio’s Parkinson’s disease drug has shown proof-of-concept in a first-in-human study, with the company to ...

Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no ...

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

The US FDA has imposed a clinical hold on Kezar Life Sciences’ IND application for zetomipzomib, aimed at treating lupus ...

Gamifying clinical trials could motivate participants to engage better with trial platforms and advance research.